Skip to main content
icon for Cyclosporiasis cases in U.S. by August 31?

Cyclosporiasis cases in U.S. by August 31?

icon for Cyclosporiasis cases in U.S. by August 31?

Cyclosporiasis cases in U.S. by August 31?

Aug 31

Aug 31

$10,668 Vol.

Aug 31, 2026
Polymarket

$10,668 Vol.

Polymarket

20,000+

$3,622 Vol.

10%

This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.As of August 24, 2026, the CDC has recorded 17,180 laboratory-confirmed domestically acquired cyclosporiasis cases since the May 1 start of the season—far exceeding the 1,180 cases reported for the same period in 2025—with 922 hospitalizations and two deaths across 48 states plus D.C. The surge stems primarily from a large multistate outbreak tied to processed iceberg lettuce imported from central Mexico, alongside at least six additional clusters under FDA and CDC investigation. Case onset dates cluster around early July, and Michigan accounts for the largest share, though weekly additions there have slowed to about 3%. With the typical season concluding August 31, final counts will incorporate any remaining reports through week’s end, while potential underdiagnosis and ongoing surveillance updates could influence the total.

This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.
Volume
$10,668
End Date
Aug 31, 2026
Market Opened
Jul 27, 2026, 11:16 PM ET

Resolver

0x65070BE91...
This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.
This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.As of August 24, 2026, the CDC has recorded 17,180 laboratory-confirmed domestically acquired cyclosporiasis cases since the May 1 start of the season—far exceeding the 1,180 cases reported for the same period in 2025—with 922 hospitalizations and two deaths across 48 states plus D.C. The surge stems primarily from a large multistate outbreak tied to processed iceberg lettuce imported from central Mexico, alongside at least six additional clusters under FDA and CDC investigation. Case onset dates cluster around early July, and Michigan accounts for the largest share, though weekly additions there have slowed to about 3%. With the typical season concluding August 31, final counts will incorporate any remaining reports through week’s end, while potential underdiagnosis and ongoing surveillance updates could influence the total.

This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.
Volume
$10,668
End Date
Aug 31, 2026
Market Opened
Jul 27, 2026, 11:16 PM ET

Resolver

0x65070BE91...
This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.

Related

icon for Will there be at least 2800 measles cases in the U.S. by August 31, 2026?

Will there be at least 2800 measles cases in the U.S. by August 31, 2026?

99%
icon for Will there be at least 2900 measles cases in the U.S. by September 30, 2026?

Will there be at least 2900 measles cases in the U.S. by September 30, 2026?

99%
icon for Will there be at least 3000 measles cases in the U.S. in 2026?

Will there be at least 3000 measles cases in the U.S. in 2026?

99%

Beware of external links.

Frequently Asked Questions

"Cyclosporiasis cases in U.S. by August 31?" is a prediction market on Polymarket with 3 possible outcomes where traders buy and sell shares based on what they believe will happen. The current leading outcome is "10,000+" at 100%, followed by "15,000+" at 100%. Prices reflect real-time crowd-sourced probabilities. For example, a share priced at 100¢ implies that the market collectively assigns a 100% chance to that outcome. These odds shift continuously as traders react to new developments and information. Shares in the correct outcome are redeemable for $1 each upon market resolution.

As of today, "Cyclosporiasis cases in U.S. by August 31?" has generated $10.7K in total trading volume since the market launched on Jul 27, 2026. This level of trading activity reflects strong engagement from the Polymarket community and helps ensure that the current odds are informed by a deep pool of market participants. You can track live price movements and trade on any outcome directly on this page.

To trade on "Cyclosporiasis cases in U.S. by August 31?," browse the 3 available outcomes listed on this page. Each outcome displays a current price representing the market's implied probability. To take a position, select the outcome you believe is most likely, choose "Yes" to trade in favor of it or "No" to trade against it, enter your amount, and click "Trade." If your chosen outcome is correct when the market resolves, your "Yes" shares pay out $1 each. If it's incorrect, they pay out $0. You can also sell your shares at any time before resolution if you want to lock in a profit or cut a loss.

The current frontrunner for "Cyclosporiasis cases in U.S. by August 31?" is "10,000+" at 100%, meaning the market assigns a 100% chance to that outcome. The next closest outcome is "15,000+" at 100%. These odds update in real-time as traders buy and sell shares, so they reflect the latest collective view of what's most likely to happen. Check back frequently or bookmark this page to follow how the odds shift as new information emerges.

The resolution rules for "Cyclosporiasis cases in U.S. by August 31?" define exactly what needs to happen for each outcome to be declared a winner — including the official data sources used to determine the result. You can review the complete resolution criteria in the "Rules" section on this page above the comments. We recommend reading the rules carefully before trading, as they specify the precise conditions, edge cases, and sources that govern how this market is settled.